MSLC ETF Analysis: Morgan Stanley Pathway | NYSE
Large Blend | NYSE, USA | Market Cap: 4.105m USD | 12M Return: 18.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.62M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 1.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Morgan Stanley Pathway Large Cap Equity ETF (MSLC) is a passively managed exchange-traded fund that focuses on large-capitalization U.S. companies. Under normal market conditions, the fund commits at least 80% of its net assets to equity securities of large cap issuers or instruments with similar economic characteristics. The manager defines its large cap universe as companies whose market capitalizations typically fall within the range of the Russell 1000® Index, a widely followed benchmark that tracks the top 1,000 U.S. companies by market value.
As a Large Blend category ETF, MSLC generally holds a mix of growth and value style large cap stocks, offering broad exposure to well-established U.S. corporations rather than concentrating on a specific sector or investment style. This blended approach is one of the most common equity ETF strategies, often used by investors seeking core U.S. equity exposure with a balance between companies priced for expansion and those perceived as undervalued relative to fundamentals.
- Morgan Stanley ETF AUM expansion lifts asset management fee revenue
- Fee compression intensifies against VOO and IVV in large cap space
- Russell 1000 Index composition shifts reshape fund holdings and flows
As of August 15, 2026, the stock is trading at USD 61.45 with a total of 50,492 shares traded. Over the past week, the price has changed by +0.38%, over one month by +3.66%, over three months by +4.75% and over the past year by +18.47%.
Current recommended Stop Loss: 60.70 (which is 1.2% or 1.4 ATR below the current price).
Morgan Stanley Pathway has no consensus analysts rating.